ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Arcus Biosciences Inc

Arcus Biosciences Inc (RCUS)

14.03
-0.09
(-0.64%)
마감 20 1월 6:00AM
14.03
0.00
(0.00%)
시간외 거래: 6:25AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
14.03
매수가
-
매도가
-
거래량
331,636
13.94 일간 변동폭 14.4499
13.51 52주 범위 20.31
market_cap
전일 종가
14.12
개장가
14.39
최근 거래 시간
65242
@
14.03
마지막 거래 시간
재정 규모
US$ 4,689,353
VWAP
14.1401
평균 볼륨(3m)
698,941
발행 주식
91,511,609
배당수익률
-
주가수익률
-4.18
주당순이익(EPS)
-3.35
매출
117M
순이익
-307M

Arcus Biosciences Inc 정보

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule... Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Camden, Delaware, USA
설립됨
-
Arcus Biosciences Inc is listed in the Pharmaceutical Preparations sector of the 뉴욕 증권거래소 with ticker RCUS. The last closing price for Arcus Biosciences was US$14.12. Over the last year, Arcus Biosciences shares have traded in a share price range of US$ 13.51 to US$ 20.31.

Arcus Biosciences currently has 91,511,609 shares in issue. The market capitalisation of Arcus Biosciences is US$1.29 billion. Arcus Biosciences has a price to earnings ratio (PE ratio) of -4.18.

RCUS 최신 뉴스

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...

Arcus Biosciences to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that...

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...

Arcus Biosciences Announces New Employment Inducement Grants

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today...

Arcus Biosciences to Participate in Two Upcoming Investor Conferences

Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, announced that...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.59-4.0355677154614.6214.7213.5159512014.05972291CS
4-1.08-7.147584381215.1116.0813.5160579314.93849841CS
12-4.12-22.699724517918.1518.9813.5169894115.83992266CS
26-1.71-10.864040660715.7418.9813.5166286916.18788135CS
52-2.79-16.587395957216.8220.3113.5171777216.41268095CS
156-20.94-59.879897054634.9739.7512.9586631421.20251932CS
2603.3831.737089201910.6549.18.5575485823.72380566CS

RCUS - Frequently Asked Questions (FAQ)

What is the current Arcus Biosciences share price?
The current share price of Arcus Biosciences is US$ 14.03
How many Arcus Biosciences shares are in issue?
Arcus Biosciences has 91,511,609 shares in issue
What is the market cap of Arcus Biosciences?
The market capitalisation of Arcus Biosciences is USD 1.29B
What is the 1 year trading range for Arcus Biosciences share price?
Arcus Biosciences has traded in the range of US$ 13.51 to US$ 20.31 during the past year
What is the PE ratio of Arcus Biosciences?
The price to earnings ratio of Arcus Biosciences is -4.18
What is the cash to sales ratio of Arcus Biosciences?
The cash to sales ratio of Arcus Biosciences is 10.97
What is the reporting currency for Arcus Biosciences?
Arcus Biosciences reports financial results in USD
What is the latest annual turnover for Arcus Biosciences?
The latest annual turnover of Arcus Biosciences is USD 117M
What is the latest annual profit for Arcus Biosciences?
The latest annual profit of Arcus Biosciences is USD -307M
What is the registered address of Arcus Biosciences?
The registered address for Arcus Biosciences is 2140 S DUPONT HWY, KENT, CAMDEN, DELAWARE, 19934
What is the Arcus Biosciences website address?
The website address for Arcus Biosciences is www.arcusbio.com
Which industry sector does Arcus Biosciences operate in?
Arcus Biosciences operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ARLAmerican Realty Investors Inc
US$ 15.93
(15.02%)
10.76k
RBOTVicarious Surgical Inc
US$ 16.382
(14.88%)
52.57k
AUNAAuna SA
US$ 8.45
(14.81%)
233.16k
MYTEMYT Netherlands Parent BV
US$ 9.45
(12.23%)
354.61k
BKSYBlackSky Technology Inc
US$ 11.71
(12.06%)
1.7M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M
DMDesktop Metal Inc
US$ 2.19
(-9.88%)
547.32k
JKSJinkosolar Holdings Co Ltd
US$ 21.23
(-9.81%)
1.55M
BODIBeachbody Company Inc
US$ 6.60
(-9.59%)
19.82k
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
QBTSD Wave Quantum Inc
US$ 5.275
(-9.21%)
76.53M
FFord Motor Company
US$ 10.18
(1.70%)
60.8M
BBDBanco Bradesco SA
US$ 1.96
(-1.01%)
59.92M
VALEVale SA
US$ 8.94
(1.94%)
59.4M
SESSES AI Corporation
US$ 0.9369
(-9.91%)
51.58M

RCUS Discussion

게시물 보기
Monksdream Monksdream 4 월 전
RCUS a buy under $14
👍️0
PennyWorld PennyWorld 1 년 전
https://seekingalpha.com/news/4005456-roche-send-anti-tigit-developers-higher-after-cancer-drug-data?ref=biztoc.com
👍️0
conix conix 3 년 전
Biotechs are starting to react to news...finally.
👍️0
dinogreeves dinogreeves 5 년 전
The stock didn't react as well as expected with the partnership, but it did hi almost my price target. This is a partnership 200 million equity investment and 175 million up front payment, which. implies no offering on the table. Makes you wonder why the stock is down, guess people were expecting a buyout. Some of these people are so lame, unbelievable.
👍️0
lovetc lovetc 5 년 전
Also in the DEF 14.....didnt see any information regarding Gilead....
👍️0
lovetc lovetc 5 년 전
shorted some and bought some put at $31 last Friday....Also today when it reached $30 I short.....I find no reason not to short above $30 lol....It will be $18 soon since the Volumn start declined....
👍️0
dinogreeves dinogreeves 5 년 전
RCUS will likely hit 40 this week and if it does that could essentially mean that there is buyout looming from GI*LD. Someone is buying heavy between 27-29 dollars, obviously they don't want it dip more than 26-27 dollars, it could be a number of reasons that is beyond any retails control.
👍️0
dinogreeves dinogreeves 5 년 전
Bought another 1000 shares on that dip, going to wait this one.
👍️0
dinogreeves dinogreeves 5 년 전
Possible huge asset buy, or outright buyout coming from GILD or even a partnership.
👍️0
dinogreeves dinogreeves 5 년 전
RCUS getting ready to pop to 33-35 dollars.
👍️0
dinogreeves dinogreeves 5 년 전
This is my letter to the shorts with margin account


That is where dummies like you are mistaken. If GILD places anywhere close to that dollar amount this stock jumps over triple digits in less then 2 hours and if there is buyout it won't even let you blink, just one share will it to the buyout price. If GOOGLE has 17% stake on this company and GILD is looking to either buy or take a stake, there must be something that you and I are not aware of the current directors sold their pervious company to Bristol for 1.5 billion dollars. There is more here than meets the eye. I am taking my chance because if no balls no glory and when that happens short margin account will be vaporized.


https://markets.businessinsider.com/news/stocks/arcus-biosciences-stock-spikes-reports-gilead-investing-cancer-drug-biotech-2020-4-1029100118
👍️0
dinogreeves dinogreeves 5 년 전
If this happens the stock will shoot up to over $200 dollars in an instant. Only if that happens.



https://markets.businessinsider.com/news/stocks/arcus-biosciences-stock-spikes-reports-gilead-investing-cancer-drug-biotech-2020-4-1029100118
👍️0
dinogreeves dinogreeves 5 년 전
News could come from GI*LD that there is a buyout. Watch for news.
👍️0

최근 히스토리

Delayed Upgrade Clock